Leaky Gut and Intestinal Permeability: What the Science Actually Supports
One-Minute Read
“Leaky gut” is an informal term, but the physiology behind it is real. The intestine is designed to be selectively permeable. Nutrients, water, electrolytes, and other needed molecules must cross the intestinal lining, while microorganisms, microbial products, antigens, and potentially harmful substances are kept under much tighter control.
When that regulation is disturbed, intestinal permeability can increase. The epithelial lining, mucus layer, tight junctions, immune system, microbiome, blood flow, diet, medications, and microbial metabolites can all influence the integrity of this barrier. Increased permeability has been demonstrated in celiac disease, inflammatory bowel disease, gastrointestinal infections, critical illness, and other conditions. It is also being studied in irritable bowel syndrome, metabolic disease, liver disease, and disorders involving the gut-brain axis.
The mistake is not using the term “leaky gut.” The mistake is allowing it to become a diagnosis for almost any combination of bloating, fatigue, brain fog, food reactions, weight gain, or inflammation.
At HormoneSynergy®, we take intestinal-barrier health seriously, while asking the more useful clinical question: why has the barrier been disrupted, and what can we do to support normal gastrointestinal physiology?
The intestinal lining is one of the most active interfaces in the human body. Every day it encounters food, digestive secretions, medications, microorganisms, microbial metabolites, environmental compounds, and an extraordinary amount of foreign material while remaining in close communication with the immune, nervous, endocrine, vascular, and metabolic systems.
For years, the term “leaky gut” sat somewhat awkwardly between conventional gastroenterology and integrative medicine. In some circles it was used too broadly, sometimes as an explanation for nearly every chronic symptom. In others, the phrase itself became easy to dismiss because “leaky gut syndrome” was not a formally defined medical diagnosis.
Research has made that argument less useful.
Intestinal permeability and intestinal-barrier dysfunction are established areas of gastrointestinal science. The barrier can become impaired. Molecules that would ordinarily be tightly regulated can cross it differently. Immune signaling can change. Microbial products can interact with tissues in ways they normally would not.
What remains much more complicated is determining when those changes are causing disease, when they are a consequence of disease, and what should be done about them in an individual patient.
For the broader HormoneSynergy® framework, see Gut Health, Microbiome, and Longevity Medicine.
The Intestine Is Supposed to Be Permeable
The intestinal barrier is sometimes described as though health depends on keeping everything inside the digestive tract from crossing into the body. That is not how digestion works.
We absorb amino acids, sugars, fatty acids, vitamins, minerals, water, electrolytes, and countless other compounds through the intestinal lining every day. The important word is selective.
A healthy intestinal barrier regulates what crosses, how it crosses, and how the immune system responds to what it encounters.
The epithelium itself consists of a single layer of cells. Between those cells are structures that include tight junctions, adherens junctions, and other proteins that help control movement through the spaces between neighboring cells. Molecules can also move through intestinal cells using transport proteins and other regulated pathways.
But the barrier is much more than that single layer of cells.
Mucus creates separation between much of the microbial population and the epithelial surface. Secretory IgA and other immune components help manage microbial exposure. Antimicrobial peptides provide another layer of defense. Blood vessels provide nutrients and oxygen. The enteric and autonomic nervous systems influence motility, secretion, blood flow, and immune activity.
The microbiome participates in this environment as well. Intestinal organisms metabolize food components, modify bile acids, interact with mucus, compete with other microbes, and produce compounds that can influence epithelial and immune function.
Intestinal permeability is therefore not simply a question of whether tight junctions are “open” or “closed.” It reflects the function of an entire biological system.
What Do We Mean by “Leaky Gut”?
In ordinary conversation, “leaky gut” generally refers to increased intestinal permeability or impaired intestinal-barrier function.
That phenomenon is real.
Researchers can measure aspects of permeability experimentally. Changes in permeability have been demonstrated in recognized gastrointestinal diseases, and the molecular mechanisms involved in epithelial transport, tight-junction regulation, mucosal immunity, and barrier repair are actively studied.
“Leaky gut syndrome” is different. There is no single accepted syndrome defined by a particular group of symptoms and confirmed by one routinely available laboratory test.
Someone can have altered intestinal permeability without having a recognizable collection of “leaky gut symptoms.” Someone else may have bloating, fatigue, brain fog, food reactions, or joint discomfort without evidence that abnormal permeability is responsible.
The term itself is not the problem. It becomes a problem when it takes the place of determining what is actually happening.
What Can Disrupt the Intestinal Barrier?
Many different processes can affect barrier function, and they do not all do so in the same way.
Celiac Disease
Celiac disease provides one of the clearest examples. In genetically susceptible people, gluten exposure triggers an immune response that damages the small-intestinal mucosa and alters intestinal-barrier physiology.
This is not treated with a generic gut-repair program. The treatment is strict gluten avoidance after an appropriate diagnosis has been established.
If celiac disease is being evaluated, patients should generally continue consuming gluten until testing has been completed. Removing gluten beforehand can make antibody testing and intestinal evaluation less reliable.
Inflammatory Bowel Disease
Crohn's disease and ulcerative colitis involve chronic intestinal inflammation in which epithelial injury, immune activation, microbial signaling, and barrier dysfunction can interact.
The relationship can move in both directions. Inflammation can damage the barrier, while a compromised barrier may increase exposure of the immune system to luminal microbial products.
Treating the inflammatory bowel disease remains the priority.
Gastrointestinal Infections
Bacterial, viral, and parasitic infections can injure epithelial cells, stimulate mucosal immunity, alter the microbiome, and affect junctional regulation.
Barrier function often improves as the infection resolves. Some patients, however, develop persistent symptoms afterward, including post-infectious disorders of gut-brain interaction.
Medications
Nonsteroidal anti-inflammatory medications such as ibuprofen and naproxen can injure gastrointestinal mucosa and increase intestinal permeability, particularly with frequent or higher-dose exposure.
Antibiotics can alter the microbial ecosystem. Chemotherapy, radiation, and other treatments can affect epithelial integrity through different mechanisms.
These effects need context. Necessary medications should not be stopped because someone has been told they have a leaky gut. Medication exposure should be reviewed alongside the reason the medication is being used.
Alcohol
Heavy or repeated alcohol exposure can affect epithelial function, tight junctions, microbial populations, inflammation, and liver physiology. Because blood from the gastrointestinal tract travels directly to the liver through the portal circulation, disruption of the gut barrier is particularly relevant to the gut-liver relationship.
Critical Illness and Physical Stress
Sepsis, major burns, trauma, intestinal ischemia, and severe systemic illness can produce substantial barrier dysfunction. These are dramatic clinical examples of the same underlying principle: intestinal permeability changes when the tissue and its regulatory systems are injured.
The Microbiome and the Intestinal Barrier
The microbiome does not simply sit inside the intestine. It participates in the environment surrounding the intestinal lining.
Microorganisms metabolize dietary compounds, interact with mucus, influence bile-acid metabolism, compete with potential pathogens, communicate with immune cells, and produce metabolites that affect epithelial physiology.
The relationship also works in the other direction. Changes in intestinal transit, inflammation, diet, medication exposure, bile acids, mucus, immune activity, and epithelial function can change the microbial ecosystem.
This is why the terms dysbiosis, microbiome imbalance, and leaky gut should not be treated as interchangeable diagnoses.
A stool microbiome profile can tell us something about organisms or microbial genes present in a stool sample. It cannot directly show whether the small-intestinal epithelium is excessively permeable, and it cannot yet tell us with certainty what an individual's “perfect” microbiome should look like.
For related discussions, see Prebiotics, Fiber, and Synbiotics and Bifidobacterium and the Gut Microbiome.
Fiber, Fermentation, and Butyrate
Diet is one of the most practical ways to influence the environment surrounding the intestinal barrier.
Many fibers and resistant carbohydrates reach the colon without being completely digested. Intestinal microorganisms can ferment these compounds and produce short-chain fatty acids, including acetate, propionate, and butyrate.
Butyrate is especially interesting because colonocytes use it as an important source of energy. It also participates in signaling involved in epithelial function, mucus, immune regulation, and the maintenance of the colonic environment.
This provides a plausible and increasingly well-defined connection between diet, microbial metabolism, and intestinal-barrier health.
It does not mean that everyone should simply consume as much fermentable fiber as possible. Someone with significant bloating, severe motility problems, active inflammatory bowel disease, intestinal narrowing, or other gastrointestinal conditions may need a different amount or type of fiber for a period of time.
The objective is not maximal fiber. It is an appropriate diet that supports microbial diversity, bowel function, nutrition, and gastrointestinal tolerance.
Our Butyrate and Short-Chain Fatty Acids and Fiber, Gut Health, and Longevity Medicine articles discuss these pathways in more detail.
Nutrition and Barrier Repair
The intestinal epithelium renews rapidly and has considerable capacity for repair. Nutrition is part of that process.
A 2024 review from Mayo Clinic investigators examined intestinal-barrier impairment, preservation, and repair and discussed the influence of dietary fat, fiber, glutamine, zinc, vitamin D, polyphenols, anthocyanins, probiotics, prebiotics, the microbiome, and microbial metabolites on barrier biology.
That does not turn any one nutrient into a treatment for “leaky gut.” Nutritional effects vary according to the underlying disease, baseline nutritional status, dose, diet, microbiome, and the outcome being measured.
The practical foundation for most people remains familiar: a varied diet containing vegetables, fruit, legumes, nuts, seeds, appropriate whole grains, adequate protein, minimally processed foods, and a range of plant compounds.
A plant- and protein-forward Mediterranean pattern fits that objective well for many patients.
See Intestinal Barrier Impairment, Preservation, and Repair: An Update.
Prebiotics and Probiotics
Prebiotics and probiotics are often discussed together, but they are not the same intervention.
Prebiotics provide substrates that selected microorganisms can use. Their effects may include changes in microbial populations, fermentation, stool characteristics, and production of metabolites such as short-chain fatty acids.
Those mechanisms can be beneficial without proving that a particular prebiotic has directly repaired intestinal permeability. A 2024 systematic review found surprisingly few human trials directly measuring permeability after prebiotic intervention and concluded that the current evidence for a direct effect remains limited.
See Limited Support for a Direct Connection Between Prebiotics and Intestinal Permeability.
Probiotics introduce specific microorganisms. Some strains have useful evidence for particular gastrointestinal conditions, while others have been studied for effects on immune signaling, microbial ecology, or aspects of epithelial function.
These effects are strain-specific. We should not assume that every Lactobacillus, Bifidobacterium, Bacillus, or multi-strain formula produces the same result.
For both prebiotics and probiotics, the more useful question is not simply whether something is “good for the gut.” It is what we are trying to accomplish in that patient.
Intestinal Permeability, IBS, and the Gut-Brain Axis
The relationship between barrier function and disorders of gut-brain interaction has become an important area of research.
Some people with irritable bowel syndrome, particularly diarrhea-predominant or post-infectious IBS, demonstrate increased permeability. The finding is not universal.
A 2025 review in Gastroenterology describes barrier function as part of a much larger communication network involving the microbiome, immune cells, enteroendocrine signaling, stress physiology, neural pathways, and the central nervous system.
That model is much more useful than reducing IBS to a single damaged barrier.
Changes in permeability may participate in the symptoms of some patients, while altered motility, visceral sensitivity, food triggers, bile acids, microbial changes, stress signaling, and other mechanisms may be more important in others.
See Intestinal Permeability in Disorders of Gut-Brain Interaction: From Bench to Bedside.
Intestinal Permeability and Metabolic Health
The intestinal barrier is also being studied well beyond traditional gastrointestinal disease.
Researchers have reported associations among permeability-related markers, obesity, visceral adiposity, insulin resistance, fatty liver disease, and systemic inflammatory signaling.
One proposed pathway involves lipopolysaccharide, or LPS, a component of the outer membrane of Gram-negative bacteria. Experimental research shows that microbial products can influence immune and metabolic pathways, and increased exposure to those products may occur when barrier regulation is altered.
Human metabolism is considerably more complicated than a straight line from diet to leaky gut to endotoxemia to disease.
Diet, visceral fat, insulin resistance, inflammation, bile acids, microbial ecology, medication exposure, and intestinal physiology influence one another. Barrier dysfunction may contribute to metabolic inflammation in some settings, while metabolic disease itself may alter the intestinal environment.
This is an important area of research, but intestinal permeability should not replace established metabolic assessment. Glucose, A1C, fasting insulin when appropriate, triglycerides, ApoB, blood pressure, body composition, visceral fat, and liver health remain much more actionable measurements in clinical practice.
For more on this pathway, see LPS, Endotoxemia, and Gut Inflammation.
Can We Measure Intestinal Permeability?
Yes, although no single measurement captures everything meant by the term intestinal barrier.
One established research approach uses orally administered probe molecules, often different sugars, followed by measurement of how much appears in urine or blood. Lactulose and mannitol have traditionally been used to evaluate aspects of small-intestinal permeability. Other probes can examine different regions or transport pathways.
Researchers can also study intestinal tissue directly using techniques such as Ussing chambers, which allow movement across epithelial tissue to be measured under controlled conditions.
These methods are useful, but they also illustrate why permeability is not one simple number. Results can vary with intestinal transit, gastric emptying, kidney function, hydration, food intake, medications, the part of the gastrointestinal tract being examined, laboratory methodology, and the particular molecules being measured.
Biomarkers measured in blood or stool have also been proposed, including intestinal fatty-acid-binding protein, LPS-related measurements, diamine oxidase, citrulline, and zonulin. Some may provide useful information in particular research or clinical settings, but none currently functions as a universal diagnostic marker of “leaky gut.”
What About Zonulin?
Zonulin is not imaginary. The signaling pathway associated with zonulin has legitimate relevance to intestinal-barrier regulation and has been studied extensively in celiac disease.
The difficulty lies with the available commercial tests.
Studies have raised questions about what some commonly used zonulin immunoassays are actually detecting. Blood values have also not consistently correlated with direct measurements of intestinal permeability.
That means a zonulin result should be interpreted cautiously and in clinical context rather than treated as a stand-alone diagnosis.
This is a useful example of a broader issue in emerging medicine. Understanding a biological pathway and having a laboratory assay related to that pathway are not the same as having a validated diagnostic test that tells us what is causing a patient's symptoms or exactly how treatment should change.
Symptoms Still Need a Differential Diagnosis
Someone can have legitimate gastrointestinal symptoms without knowing the mechanism behind them.
Bloating may occur with constipation, lactose intolerance, celiac disease, IBS, altered gastrointestinal motility, fermentable-carbohydrate intolerance, small-intestinal bacterial overgrowth in an appropriate clinical setting, or other conditions.
Diarrhea has an equally broad differential. Fatigue and difficulty concentrating extend the possibilities well beyond the gastrointestinal tract.
This is why symptoms alone cannot diagnose abnormal permeability.
When a person says they feel better after changing their diet, improving bowel function, treating a gastrointestinal disorder, or modifying something affecting the microbiome, that improvement is clinically meaningful. It does not require us to assume that every benefit occurred because a previously “leaky” intestine was sealed.
Our job is to understand as much of the physiology as reasonably possible while treating the patient in front of us.
Treat What Is Disrupting the Barrier
When an underlying cause can be identified, addressing it is usually the most effective way to support barrier recovery.
Celiac disease requires gluten avoidance. Inflammatory bowel disease requires appropriate disease-directed therapy. Gastrointestinal infections are managed according to the organism and clinical setting. Medication-related injury requires a thoughtful review of the medication and its indication. Heavy alcohol exposure deserves attention for intestinal, hepatic, cardiovascular, neurologic, and metabolic reasons.
Nutrition, probiotics, prebiotics, fiber, glutamine, polyphenols, and other supportive approaches may have a role, but they work best when we know what we are trying to accomplish.
That is a different approach from automatically placing every patient with bloating, fatigue, or food intolerance on the same multi-product “gut repair” protocol.
Supporting a Healthy Intestinal Barrier
For most people, maintaining a healthy intestinal environment begins with fairly ordinary habits.
Eat a varied, nutrient-dense diet. Include adequate protein. Include a range of plant foods and fibers when they are tolerated. Allow the microbiome access to different fermentable substrates rather than depending indefinitely on a very narrow diet.
Exercise regularly. Physical activity supports insulin sensitivity, circulation, gastrointestinal motility, and metabolic health. Sleep adequately. Limit heavy alcohol exposure. Do not smoke. Use antibiotics when they are medically appropriate rather than avoiding them when they are needed or using them casually when they are not.
Review frequent NSAID use when relevant. Address constipation and abnormal motility rather than allowing them to persist indefinitely. Evaluate persistent gastrointestinal symptoms rather than assuming they are simply normal.
None of these interventions needs to be marketed as a cleanse or a gut-healing program to benefit intestinal physiology.
Where Supplements May Fit
There are situations in which targeted nutritional or gastrointestinal support is reasonable.
Glutamine is an important fuel source for intestinal cells and has been investigated in several conditions involving intestinal stress or altered permeability. Zinc and vitamin D participate in epithelial and immune physiology. Polyphenols and plant compounds interact with both intestinal cells and the microbiome. Specific probiotics may be useful for particular indications. Prebiotic fibers can support microbial fermentation when they are well tolerated.
The evidence is not identical for each intervention, and none should be presented as a universal method of “sealing the gut.”
The decision is better made by asking what the patient needs. Are we correcting a nutritional deficiency? Improving dietary fiber intake? Supporting bowel regularity? Using a probiotic strain with evidence for a particular condition? Supporting recovery after an intestinal illness? Trying to improve dietary diversity or microbial fermentation?
That gives supplementation a clinical purpose rather than turning it into a ritual.
Explore gut and digestive support:
Where Intestinal Barrier Health Fits in Longevity Medicine
The intestine participates in far more than digestion. It influences nutrient availability, immune signaling, microbial metabolism, inflammation, liver physiology, glucose regulation, and communication between the gut and nervous system.
That makes intestinal health relevant to preventive and longevity medicine.
It does not make intestinal permeability a stand-alone longevity biomarker, and we do not have evidence that improving a commercial “leaky gut” laboratory value extends lifespan.
The clinical value is more practical.
A patient whose celiac disease has gone undiagnosed may develop nutritional deficiencies and bone loss. Poorly controlled inflammatory bowel disease has consequences far beyond the intestinal tract. Chronic diarrhea or malabsorption can affect nutritional status. Metabolic disease can interact with liver, microbial, and intestinal physiology. Persistent gastrointestinal symptoms can profoundly affect quality of life.
Those problems deserve attention within comprehensive preventive medicine.
At HormoneSynergy®, we take intestinal permeability seriously without asking it to explain everything. We look at gastrointestinal symptoms, diet, medication exposure, microbiome-related factors, metabolic health, inflammation, sleep, stress physiology, nutritional status, and established gastrointestinal disease together.
The objective is not to make the intestine impermeable. It is to preserve the remarkable selectivity of the barrier, identify what is interfering with it when something goes wrong, and support recovery with interventions that have a defensible reason for being there.
Gut Health and Longevity Resources
- Gut Health, Microbiome, and Longevity Medicine
- Fiber, Gut Health, and Longevity Medicine
- Prebiotics, Fiber, and Synbiotics
- Butyrate and Short-Chain Fatty Acids
- LPS, Endotoxemia, and Gut Inflammation
- Akkermansia muciniphila
- Bifidobacterium and the Gut Microbiome
- Brain Longevity and Cognitive Health
- Gut Health, Histamine & Probiotics
Frequently Asked Questions
Is leaky gut real?
Increased intestinal permeability and intestinal-barrier dysfunction are real physiological phenomena and occur in several recognized diseases. “Leaky gut” is commonly used as an informal description of that biology. It should not be assumed to be a single syndrome responsible for every digestive or systemic symptom.
Is intestinal permeability always abnormal?
No. A healthy intestine must be selectively permeable so nutrients, water, electrolytes, and other appropriate molecules can be absorbed. The concern is inappropriate or excessive permeability associated with disruption of normal barrier regulation.
What diseases can affect intestinal permeability?
Altered permeability is well documented in celiac disease, inflammatory bowel disease, gastrointestinal infections, critical illness, and other forms of intestinal injury. It has also been studied in subsets of people with IBS, metabolic disease, liver disease, and several inflammatory conditions.
What symptoms prove that someone has leaky gut?
No symptom or combination of symptoms proves that intestinal permeability is abnormal. Bloating, diarrhea, constipation, abdominal discomfort, fatigue, food-related symptoms, and cognitive complaints have many possible causes.
Can zonulin diagnose leaky gut?
Not reliably by itself. Zonulin-related signaling is relevant to intestinal-barrier biology, but commercially available assays have analytical and clinical limitations. A zonulin result should not be treated as a stand-alone diagnosis.
What is the best test for intestinal permeability?
There is no single test that measures every component of intestinal-barrier function. Oral sugar-probe testing is used extensively in research and some specialty settings. More direct tissue methods and several indirect biomarkers are also used in research, each with different strengths and limitations.
Do probiotics repair intestinal permeability?
Specific probiotic strains may influence microbial, immune, and epithelial physiology and may be useful for certain gastrointestinal conditions. Evidence cannot be generalized to all probiotic products or interpreted as proof that probiotics universally repair a leaky gut.
Do prebiotics help the intestinal barrier?
Prebiotics can alter microbial fermentation and the intestinal environment. Direct human evidence that prebiotic supplementation consistently improves measured intestinal permeability remains limited, although prebiotic foods and fibers may provide other gastrointestinal and metabolic benefits.
Can the intestinal barrier heal?
Yes. The intestinal epithelium renews rapidly and has substantial capacity for repair. Recovery depends on the cause. Treating celiac disease, controlling intestinal inflammation, resolving an infection, reducing harmful exposures, improving nutrition, and supporting the surrounding intestinal environment can all be relevant.
Selected Clinical References
Intestinal Barrier Impairment, Preservation, and Repair: An Update — 2024
Intestinal Permeability Disturbances: Causes, Diseases and Therapy — 2024
Intestinal Barrier Permeability: The Influence of Gut Microbiota, Nutrition, and Exercise — 2024
The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation
This article is for educational purposes and does not replace individualized medical evaluation, diagnosis, or treatment.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →